$5,94
▼ $-0,17
(-2,78%)
Vol. 2.4M
6
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$1.4B
ROE
-36,9%
Margine
-14,2%
D/E
131,02
Beta
0,51
52W
$3–$7
Consenso Wall Street
18 analisti · Apr 202610
Acquisto forte
7
Compra
1
Mantieni
0
Vendi
0
Vendita forte
94,4%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 50,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $0,01 | $0,00 | $-0,01 |
| Set 2025 | $-0,06 | $0,00 | +$0,06 |
| Giu 2025 | $-0,14 | $-0,08 | +$0,06 |
| Mar 2025 | $-0,12 | $-0,17 | $-0,05 |
Ricavi e utili trimestrali
| Trimestre | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Ricavi | $116.1M | $74.1M | $97.7M | $110.3M | $125.2M |
| Utile netto | $4.6M | -$41.1M | -$19.1M | -$969K | -$407K |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -36.6% | -36.6% | -36.6% | -36.9% | -36.9% | -36.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -19.5% | -14.6% | -14.6% | -14.2% | -14.2% | -14.2% |
| Gross Margin | 87.3% | 84.8% | 84.8% | 88.2% | 88.2% | 88.2% |
| D/E Ratio | 144.37 | 144.37 | 144.37 | 131.02 | 131.02 | 131.02 |
| Current Ratio | 4.30 | 4.30 | 4.30 | 4.41 | 4.41 | 4.41 |
Rapporti chiave
ROA (TTM)
-12,6%
P/S (TTM)
3,56
P/B
6,9
EPS (TTM)
$-0,24
CF/Share
$0,01
Crescita ricavi 3A
+220,9%
52W High
$6,78
52W Low
$3,21
$3,21
Intervallo 52 settimane
$6,78
Salute finanziaria
Flusso di cassa libero
$20.6M
Debito netto
$140.0M
Liquidità
$68.0M
Debito totale
$208.0M
Aggiornato al Dic 31, 2025
Як ARDX виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка ARDX vs аналоги Biotechnology
P/E
—
▼
0%
sotto
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
3,6
▼
72%
sotto
peer
(12,9)
vs Peer
vs Settore
Sottovalutato
P/B
6,9
▲
182%
sopra
peer
(2,5)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість ARDX vs аналоги Biotechnology
ROE
-36,9%
▲
45%
sopra
peer
(-67,3%)
vs Peer
vs Settore
Sotto media
Net margin
-14,2%
▲
95%
sopra
peer
(-286,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
88,2%
▲
12%
sopra
peer
(78,6%)
vs Peer
vs Settore
Debole
ROA
-12,6%
▲
73%
sopra
peer
(-46,7%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя ARDX vs аналоги Biotechnology
D/E ratio
131,0
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
4,4
▼
1%
sotto
peer
(4,4)
vs Peer
vs Settore
In linea
Beta
0,5
▼
48%
sotto
peer
(1,0)
vs Peer
vs Settore
Più volatile
Радар фундаменталів ARDX
ARDX
Mediana peer
Industria
ARDX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
ARDX vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
RAAB MICHAEL G
Chief Executive Officer · Mar 16
20833 shs
RAAB MICHAEL G
Chief Executive Officer · Mar 16
41666 shs
RAAB MICHAEL G
Chief Executive Officer · Feb 24
20833 shs
RAAB MICHAEL G
Chief Executive Officer · Feb 24
41666 shs
MOTT DAVID M
Director · Feb 20
333333 shs
RAAB MICHAEL G
Chief Executive Officer · Feb 20
45982 shs
WILLIAMS LAURA A
Officer · Feb 20
8176 shs
KELLIHER MICHAEL
Officer · Feb 20
9595 shs
FOSTER ERIC DUANE
Officer · Feb 20
10439 shs
BRADY JAMES PARKER
Officer · Feb 20
2543 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 32,0%Blackrock Inc.
8,62%
$115.8M
Vanguard Group Inc
7,74%
$104.0M
Janus Henderson Group PLC
5,92%
$79.5M
State Street Corporation
4,86%
$65.3M
Millennium Management Llc
4,86%
$65.3M
Aggiornato al Dic 31, 2025